Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
6 resultat
Therapeutic compositions and methods for disorders associated with neuronal degeneration
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE DISCLOSURE
The present disclosure relates to compositions and methods for the treatment of disorders associated with neuronal degeneration. More specifically, the present disclosure relates to of a mutant form of erythropoietin (EPO) for the treatment of disorders associated with
Therapeutic compositions and methods for disorders associated with neuronal degeneration
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE DISCLOSURE
The present disclosure relates to compositions and methods for the treatment of disorders associated with neuronal degeneration. More specifically, the present disclosure relates to of a mutant form of erythropoietin (EPO) for the treatment of disorders associated with
Methods and compositions for the treatment of axonal and neuronal degeneration
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
SEQUENCE LISTING
This application contains a Sequence Listing submitted electronically as a text file by EFS-Web. The text file, named "6837-1 Sequence Listing ST25", has a size in bytes of 4 KB, and was recorded on Jun. 13, 2013. The information contained in the text file is incorporated herein by
Methods and compositions for the treatment of axonal and neuronal degeneration
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
The present invention generally relates to methods, compositions and materials for treatment and prevention of axonal and neuronal degeneration and related nerve injury, toxic insults or neurodegenerative disorders.
BACKGROUND OF THE INVENTION
Neurodegenerative disorders are
Glutathione preparation and method for production thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This patent application is the U.S. national phase of International Patent Application No. PCT/JP2007/069433, which was filed on Oct. 4, 2007, and which claims priority to Japanese Patent Application No. 272668/2006, filed on Oct. 4, 2006.
TECHNICAL FIELD
The
Formulations of Factor VIIa inhibitors and utility
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The field relates to the use of novel nanoparticle formulations and chemical structures that include vasodilator Factor VIIa inhibitors to treat vascular disorders in a subject.
BACKGROUND OF THE INVENTION
Vascular endothelial-mediated disorders including sickle cell diseases,
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
